[Pharmacology of benzoctamine, a new psychotropic agent].
D000378:Agonistic Behavior / Q000187:drug effects; D000661:Amphetamine / Q000037:antagonists & inhibitors; D000700:Analgesics; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology* / Q000633:toxicity; D000927:Anticonvulsants; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003214:Conditioning, Classical / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004569:Electroencephalography; D008297:Male; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors; D009125:Muscle Relaxants, Central; D009132:Muscles / Q000187:drug effects; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D012890:Sleep / Q000187:drug effects
D000700:Analgesics; D000873:Anthracenes; D000927:Anticonvulsants; D009125:Muscle Relaxants, Central; D011619:Psychotropic Drugs; D002707:Chlordiazepoxide; D009020:Morphine; D000661:Amphetamine; D002746:Chlorpromazine